Sun Pharmaceutical Industries, Inc.

This study is following up with 1,000 adults who have moderate to severe alopecia areata, a condition causing patchy hair loss. The goal is to see if an oral medication called CTP-543 is safe and continues to help regrow hair when taken for a longer period. Participants had alrea…

This study is testing a reformulated gel that is activated by blue light to treat rough, scaly patches of sun-damaged skin (actinic keratosis) on the arms. About 260 adults with 4 to 8 of these patches on one arm will receive either the active gel or a placebo gel, followed by li…

This study is testing a reformulated gel that is activated by a special blue light to treat rough, scaly spots caused by sun damage (actinic keratosis) on the face or bald scalp. About 160 adults with 4 to 8 of these spots will receive either the active gel or a placebo gel, foll…